ArticleJournal of neurology2025
Differentiation between anti-CASPR2 encephalitis with initial psychiatric symptoms and primary psychiatric disorders, and a diagnostic prediction model: a prospective descriptive study.
Article in Journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundAnti-contactin-associated protein-like 2 (anti-CASPR2) encephalitis is highly susceptible to misdiagnosis as a primary psychiatric disorder when isolated psychiatric symptoms occur in its early stage.
methodsData on patients with acute or subacute psychiatric symptoms from January 2023 to March 2024 were collected and divided into an anti-CASPR2 encephalitis group (case group) and a primary psychiatric disorder group (control group). The differences between the two groups were evaluated, and logistic regression analysis was conducted to identify significant predictors of anti-CASPR2 encephalitis. Receiver operating characteristic (ROC) curve and decision curve analysis were used to evaluate the predictive performance and clinical utility of the anti-CASPR2 encephalitis model.
resultsThe study included 18 patients with anti-CASPR2 encephalitis and 14 with primary psychiatric disorders. Patients in the case group were older on average and had a shorter onset time compared to the control group (P < 0.05). The case group reported fewer social life events and had a higher prevalence of positive cranial magnetic resonance imaging (MRI) findings and serum CASPR2 antibodies (P < 0.05). Binary logistic regression identified older age, shorter onset time and abnormal cranial MRI findings as independent risk factors for anti-CASPR2 encephalitis. The predictive model demonstrated high concordance with clinical observations and strong clinical utility.
conclusionAnti-CASPR2 encephalitis is more likely to occur in elderly patients with an acute onset, fewer social stressors, and abnormal cranial MRI findings. This diagnostic prediction model provides a reliable tool for the early differentiation between anti-CASPR2 encephalitis and primary psychiatric disorders.
Indexed as
Identifiers
41298867What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.